|
Vanguard Pharmaceutical Corporation (VGPH) - Strategic SWOT Analysis Review Vanguard Pharmaceutical Corporation (Vanguard) is engaged in research, development, manufacture, and sale of generic and oncology pharmaceuticals. It principally offers haematological and supportive care drugs to cure cancer. The company's product portfolio comprises antibiotics, antibacterial, antimalaria, anti diarrhoeal, tranquilizer, antacid, heart, anti-diabetic, cholesterol, and steroid products. Its products are available in various dosage forms, including tablets, hard gelatin capsules, dry syrups, and oral powders and liquids. Currently, the company is underway research for innovative non-invasive cure methods targeting cancer, including telomerase inhibitor therapy, nanoparticle therapies, and low power radio frequency radiation for treatment of cancer. Vanguard products are majorly supplied to Brazil, Peru, Paraguay and Cameroon. In addition, it offers contract services for clinical research processes to pharmaceutical companies. Its owns a manufacturing facility, which has the capacity to manufacture 28 million compressed tablets,175 thousand oral liquids, 3.5 million hard gelatin capsules, and 70 thousand dry syrup units per week. Vanguard is headquartered at San Antonio in Texas, the US. (http://www.companyprofilesandconferences.com/report/Vanguard-Pharmaceutical-Corporation-VGPH-Strategic-SWOT-Analysis-Review.html) This comprehensive SWOT profile of Vanguard Pharmaceutical Corporation provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of Vanguard Pharmaceutical Corporation and deliver this direct to you in pdf format within two business days (excluding weekends). The profile contains critical company information including*, - Business description – A detailed description of the company's operations and business divisions. - Corporate strategy – Analyst's summarization of the company's business strategy. - SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives' employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. For more information kindly visit : http://www.companyprofilesandconferences.com/report/Vanguard-Pharmaceutical-Corporation-VGPH-Strategic-SWOT-Analysis-Review.html Or Contact us at : Company Profiles and Conferences Tel: +91 22 2756 1536 Fax: +91 22 2757 9131 Email: info@companyprofilesandconferences.com Website: www.companyprofilesandconferences.com
Related Articles -
Company Financials, Company Insight, Company Reports, SWOT Analysis,
|
